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Abstract
Background & Aims—An association between gastric cancer and the rs2294008 (C>T)
polymorphism in the prostate stem cell antigen (PSCA) gene has been reported for several Asian
populations. We set out to determine whether such an association exists in Caucasians.
Methods—We genotyped 166 relatives of gastric cancer patients, including 43 H pylori-infected
subjects with hypochlorhydria and gastric atrophy, 65 infected subjects without these
abnormalities, 58 H pylori-negative relatives, and 100 population controls. Additionally, a
population-based study of chronic atrophic gastritis provided 533 cases and 1054 controls. We
then genotyped 2 population-based case-control studies of upper gastrointestinal cancer: the first
included 312 gastric cancer cases and 383 controls; the second included 309 gastric cancer cases,
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159 esophageal cancer cases, and 211 controls. Odds ratios were computed from logistic models
and adjusted for confounding variables.
Results—Carriage of the risk allele (T) of rs2294008 in PSCA was associated with chronic
atrophic gastritis (adjusted odds ratio [OR] = 1.5; 95% confidence interval [CI], 1.1–1.9) and non-
cardia gastric cancer (OR = 1.9; 95% CI, 1.3– 2.8). The association was strongest for the diffuse
histological-type (OR = 3.2; 95% CI, 1.2–10.7). An inverse association was observed between
carriage of the risk allele and gastric cardia cancer (OR = 0.5; 95% CI, 0.3–0.9), esophageal
adenocarcinoma (OR = 0.5; 95% CI, 0.3–0.9), and esophageal squamous cell carcinoma (OR =
0.4; 95% CI, 0.2–0.9).
Conclusions—The rs2294008 polymorphism in PSCA increases the risk of non-cardia gastric
cancer and its precursors in Caucasians but protects against proximal cancers.
Keywords
Stomach cancer; esophageal cancer; genetic polymorphisms, cancer genetics
Introduction
Upper gastrointestinal cancers represent a significant global health burden. Gastric and
esophageal cancers were, respectively, the second and sixth most common causes of cancer-
related mortality worldwide in 2008, accounting for over one million deaths1.
The identification of Helicobacter pylori as the major acquired etiological agent responsible
for gastric carcinogenesis2,3 revolutionized our understanding of the inflammation and
cancer paradigm, and prompted candidate gene approaches to host genetic susceptibility4,5.
Consequently, gastric cancer is arguably better understood in terms of genetic susceptibility
than other gastrointestinal malignancies. We, and other authors, have previously reported an
increased risk of gastric cancer and its precursors (gastric atrophy and hypochlorhydria) in
association with polymorphisms in pro-inflammatory cytokine genes (IL-1B, IL-1RN, TNFA
and IL-10), and genes involved in the innate immune response (TLR4)4–8. Recently,
genome wide association studies (GWAS) have permitted the identification of novel, high
prevalence, low penetrance genetic polymorphisms associated with complex human traits,
including sporadic cancer risk. Unlike candidate gene approaches, no prior knowledge of the
locations of the loci or functions of the gene products is required. Indeed, the mechanism of
action of many GWAS-identified genetic variants remains unknown, and the ability to
stratify individual cancer risk on the basis of these variants is limited9.
Recently, the Study Group of the Millennium Genome Project for Cancer published findings
of a two-stage GWAS, which demonstrated an association between the rs2294008 single
nucleotide polymorphism (SNP) in the prostate stem cell antigen gene (PSCA), and the risk
of gastric cancer in Japanese10. The authors subsequently validated the association in a
Korean case-control study of gastric cancer. In both the Japanese and Korean study groups,
the association was strongest for the diffuse histological-type of gastric cancer (OR = 4.18;
95% CI, 2.88–6.21 for Japanese). The finding of an association between gastric cancer and
rs2294008 has now been replicated in several, independent, Asian case-control studies11–14,
and was also confirmed in a recent gastric cancer GWAS in a Chinese population15.
Limited functional data exist on the effect of the rs2294008 C>T transition, however results
from a reporter assay suggest that the T allele reduces upstream PSCA transcriptional
activity10.
Whether the rs2294008 polymorphism confers increased risk of gastric cancer in Caucasian
populations has not yet been established. Furthermore, it is not known at what stage in
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gastric carcinogenesis the PSCA polymorphism exerts its effect. In order to address these
questions, we performed a genotyping study that included four independent, Caucasian,
case-control studies, comprising one study of gastric cancer, one study of gastric and
esophageal cancers, and two studies of chronic atrophic gastritis.
Materials and Methods
Study populations
To determine whether the rs2294008 polymorphism is associated with the risk of
premalignant change in the stomach, we employed two case-control studies of chronic
atrophic gastritis (CAG). In the Scottish Gastric Cancer Relatives Study, a cohort of 166
healthy, Caucasian, first-degree relatives of gastric cancer patients was recruited from the
West of Scotland. These subjects have previously been shown to have a high prevalence of
hypochlorhydria (pentagastrin-stimulated peak acid output <15mmolh−1) in association with
H pylori infection (assessed by 14C urea breath test, serology, urease test, culture, and
histology) and histological evidence of gastric atrophy16. Of the 108 subjects infected with
H pylori, 43 had hypochlorhydria and gastric atrophy and 65 had normal or high gastric acid
secretion. Fifty-eight subjects were free of H pylori infection and had normal gastric
histology and physiology. One hundred unselected cord blood samples from the West of
Scotland were available as population controls, and were used to assess the distribution of
alleles at the rs2294008 locus. The two H pylori-infected subgroups served as cases and
controls for CAG.
The second CAG study group was derived from ESTHER, a large population-based cohort
study initiated to investigate new approaches to the early detection and prevention of chronic
disease in the elderly17. A total of 9,953 participants from Saarland, a federal state in the
south-west of Germany, were recruited by their general practitioners during routine health
check-ups. At baseline examination, 533 participants without gastric cancer were
serologically defined as having CAG by ELISA (Pepsinogen I < 70 ng/ml and pepsinogen I/
pepsinogen II ratio < 3)17–19. A stratified random sample of 1054 controls was included in
the present analysis, with controls frequency-matched to cases by sex and 5-year age
group20,21.
In order to investigate the influence of the rs2294008 polymorphism on upper GI cancer risk
in Caucasians, two independent, population-based, case-control studies were utilized. The
first was a gastric cancer study derived from a Caucasian population in Warsaw, Poland, in
which DNA samples were available from 312 gastric cancer cases (predominantly non-
cardia cancers) and 383 randomly-selected population controls, matched by age and sex22.
The second was a multi-centre esophageal and gastric cancer study conducted in three
distinct geographic areas of the United States holding population-based cancer registries23;
DNA samples were available from 309 gastric cancer cases (123 cardia and 186 non-cardia;
90% Caucasian), 159 esophageal cancer cases (52 squamous cell carcinoma [ESCC] and
107 adenocarcinoma [EAC], 90% Caucasian), and 211 matched population controls (94%
Caucasian).
The institutional review boards of the participating centers granted ethical approval for the
study, and written informed consent was obtained from all subjects.
Genotyping
The German CAG study DNA samples were genotyped using Sequenom's MassARRAY®
system (Sequenom, San Diego, CA), performing iPLEX® single base primer extension and
matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry,
as described elsewhere24. Genotyping calls were made in real-time with the MassARRAY®
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RT software, yielding a call rate of 98% for rs2294008. For the Scottish, Polish and US
study groups, DNA samples were genotyped by real-time PCR allelic discrimination using
the ABI 7900HT Fast Sequence Detection System (Applied Biosystems, Foster City, CA). A
pre-designed TaqMan® SNP genotyping assay was employed, utilizing minor groove
binding probes 5′-labeled with VIC or FAM fluorophores to detect the C and T alleles of
rs2294008 (Applied Biosystems)25. Genotyping calls were possible in over 99% of samples
by analysis of real-time and end-point data. Genotyping results were validated by direct
sequencing of selected samples. Real-time PCR allelic discrimination and MALDI-TOF
have previously been shown to yield highly comparable, accurate, genotyping results when
used in parallel26.
Statistical Analysis
Hardy-Weinberg equilibrium (HWE) of alleles at the polymorphic locus was assessed by χ2
statistics. Odds ratios (OR) with Cornfield 95% confidence intervals (CIs) were computed
by logistic regression using Statistical Analysis Software (SAS) version 9.1 (SAS Institute
Inc., Cary, USA), for the German study data, and STATA version 7.0 software (STATA
Press, College Station, TX) for the Scottish, Polish and US study data. ORs for the Scottish
study data were adjusted for age and within-family correlation, to account for samples
derived from several members of a given family. ORs for the German, Polish, and US
studies were adjusted for age and sex. Additional models, performed to adjust for the
potential confounding effects of H pylori infection, smoking, and, in the US study only,
ethnicity, made no material difference to the ORs.
Results
The alleles at the rs2294008 polymorphic locus were in Hardy-Weinberg equilibrium, with
non-significant χ2 values, in all control populations with the exception of the Polish controls,
where there was a heterozygote deficit (HWE χ2 = 6.43, p = 0.011). The frequency of the
variant allele in the control populations ranged from 0.369 (Scottish) to 0.518 (Polish).
The rs2294008 polymorphism is associated with the risk of gastric cancer precursors
In both the German and Scottish study populations, an association was observed between the
risk allele (T) of rs2294008 and CAG (Table 1). For the German study, the OR for
individuals carrying one copy of the risk allele was 1.4 (95% CI, 1.1–1.8), whilst for T/T
homozygotes, the OR was 1.7 (95% CI, 1.2–2.3). Both inheritance models yielded
significant associations, with the higher OR of 1.5 (95% CI, 1.1–1.9) observed in a dominant
model. In the Scottish study, the T allele conferred increased risk of atrophy and
hypochlorhydria, with the T/T genotype yielding an OR of 4.1 (95% CI, 1.3–12.7) in a
recessive model (Table 1). Analysis of the German and Scottish study populations did not
reveal an association between rs2294008 and the risk of H pylori infection (data not shown).
The rs2294008 polymorphism is a risk factor for non-cardia gastric cancer in Caucasians
A positive association was observed between the rs2294008 risk allele and non-cardia
gastric cancer in the US study population, and all-site gastric cancer in the Polish study
population (Table 2). In the Polish study (where cases were predominantly non-cardia
cancers) for all anatomic sub-sites combined, individuals carrying one or two copies of the
risk allele had similar ORs of 1.9 (95% CI, 1.2–2.9 and 1.2–3.0 respectively). No association
was detected when the small sub-group (n = 36) of cardia cancer cases were analyzed in
isolation (data not shown). In keeping with existing literature, the association was strongest
for the diffuse histological-type of gastric cancer, with an OR of 3.7 (95% CI, 1.3–12.9) for
T/T homozygotes. The association did, however, hold for the intestinal type also, giving an
OR of 1.6 (95% CI, 1.0–2.6) in a dominant model.
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In the US study population, the association between the rs2294008 risk allele and non-cardia
cancer, and diffuse histological-type, was only significant in recessive models, yielding an
OR of 1.9 in both cases (95% CI, 1.2–3.0 and 1.1–3.5 respectively). No association was
observed in the US study between rs2294008 and intestinal histological-type. Additionally,
no relationship was detected between rs2294008 and risk of H pylori infection in either the
US or Polish study populations (data not shown).
The rs2294008 polymorphism is inversely associated with the risk of esophageal and
gastric cardia cancers
An inverse association was observed between the rs2294008 polymorphism and proximal
cancers of the upper gastrointestinal tract in the US study (Table 2; US study). For gastric
cardia cancer, EAC and ESCC, this inverse association appeared strongest for individuals
carrying one copy of the risk allele, with ORs of 0.5 (95% CI, 0.3–0.9), 0.5 (95% CI, 0.3–
0.9) and 0.4 (95% CI, 0.2–0.8) respectively. Similar associations were obtained for the three
proximal cancers in dominant models.
Discussion
In the present study, we demonstrate that the rs2294008 polymorphism in the PSCA gene,
previously described as a risk factor for gastric cancer in Asians, is associated with gastric
cancer and its precursors (gastric atrophy and hypochlorhydria) in Caucasian populations. In
keeping with existing literature, the association is strongest for tumors of diffuse
histological-type. We also report the additional novel findings of divergent effects of the
polymorphism on cardia and non-cardia gastric cancers, and an inverse association with
esophageal cancer of both squamous and adenocarcinoma histotypes.
The main strength of this study is replication of the association with CAG and gastric cancer
in multiple independent populations. We acknowledge that the study has potential
weaknesses. The limited size of some of the case-control study subgroups increases the
chance of over or underestimating the magnitude of effect of the polymorphism. The
serological criteria employed for the classification of CAG in the German study have been
used extensively in epidemiological studies, and associate with established risk factors for
CAG in the ESTHER study population17; we cannot, however, exclude bias as a results of
serological misclassification of CAG. We recognize that violation of HWE in the Polish
controls is an additional potential source of bias. Although the deviation from HWE has
likely occurred by chance, it could indicate unexpected population structure, or a systematic
genotyping error. Importantly, the same genotyping methodology did not result in deviation
from HWE in the US or Scottish controls. Furthermore, numerous previous studies of other
markers in this population have not suggested population stratification4,7,8. Although
intended as a study of Caucasians, the US study did contain a minority of non-Caucasian
subjects. Given that we genotyped a single polymorphism, and that functional evidence for
rs2294008 derives from only one study10, we cannot exclude the possibility that the
observed associations are partly or entirely due to linkage with another functional
polymorphism in the same region.
Our data contain several interesting observations worthy of further consideration. An
association between rs2294008 and intestinal histological-type was only detected in the
Polish study. One possible reason for this is the limited number of intestinal-type cases in
the US study; however one cannot dismiss the possibility that this difference has arisen as a
result of population-specific effects mediated through gene-gene or gene-environment
interactions27. Similarly, background genetic or environmental exposures may account for
the differences observed in inheritance models between the US and Polish studies for non-
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cardia cancer and diffuse histological-type, although our sample sizes are too small to
confidently make such assertions.
The inverse association between rs2294008 and gastric cardia cancer was only observed in
the US study; however the number of Polish cardia cases may well have been too small to
detect a similar effect. Interestingly, in a recent GWAS in a Chinese population, Abnet et al.
found no overall association between rs2294008 and gastric cancer15. Sub-group analysis,
however, revealed a positive association between rs2294008 and non-cardia gastric cancer,
yet no association with cardia cancer. A similar dichotomous effect for rs2294008 was
observed in the Chinese case-control series of Wu et al.11. Given that cardia cancer itself
appears to be an etiologically heterogeneous condition28, the opposing effect of rs2294008
on cardia and non-cardia cancer risk observed in our Caucasian population is at least
biologically plausible. Interestingly, in per-genotype analyses, the inverse risk for proximal
cancers was only significant in C/T heterozygotes. Whilst it is theoretically possible that this
reflects a biologically-mediated heterozygote advantage, the numbers of homozygote risk
allele cases were small and, since dominant inheritance models gave similar results, it seems
more likely that this discrepancy is due to small sample size. Replication of our proximal
cancer data in additional populations would help to robustly validate these findings.
Assuming that the divergent effect of the rs2294008 polymorphism on cancer risk at
different anatomic sites is genuine, it is not necessarily all that surprising. It is well
recognized that proximal and distal upper gastrointestinal cancers have quite different
etiologies. The opposing effect may be partly explained in relation to gastric atrophy and
hyposecretion. H pylori infection and gastric atrophy, risk factors for non-cardia gastric
cancer, are inversely associated with reflux esophagitis and EAC29,30. One might therefore
expect a genetic polymorphism that predisposes to CAG to be inversely associated with
EAC. For ESCC, the association may be less easy to explain since recent evidence suggests
that an association exists between ESCC, gastric atrophy and hyposecretion, although the
association is independent of the severity of gastric atrophy31. From a genetic standpoint,
similar opposing effects have been described for other GWAS-identified SNPs such as
rs6983267, which confers risk for prostate cancer and smoking-related oropharyngeal
cancers, but is inversely associated with bladder cancer32.
The precise function of PSCA in vivo is not known. A member of the lymphocyte antigen 6
(Ly-6) superfamily of glycosylphosphatidylinositol (GPI)-anchored cell surface proteins,
PSCA was first identified by Reiter et al. as a marker overexpressed in a prostate cancer
xenograft model33. PSCA expression has subsequently been implicated in prostate cancer
stage, Gleason score, and metastatic potential34–36. PSCA has been accorded a somewhat
misleading name. Despite its 30% nucleotide homology with stem cell antigen type-2
(SCA-2)33, another member of the Ly-6 family, PSCA is not a stem cell marker, nor is its
expression restricted to prostatic tissue, with PSCA protein expression having been
demonstrated in human trophoblast, kidney and stomach10,34. In addition to prostate
cancer, PSCA appears to be upregulated in a proportion of other human solid tumors
including those of the pancreas, urothelium, kidney and ovary37–40. In contrast, gastric and
esophageal cancers display reduced or absent PSCA expression10,33,38,41. Interestingly,
PSCA also appears to be downregulated in gastric intestinal metaplasia, the precursor lesion
of intestinal-type gastric cancer10. In keeping with our data, this suggests that PSCA may
have a role in the early stages of gastric carcinogenesis. In normal gastric mucosa, PSCA
protein expression appears to be localized to dividing and differentiating cells in the isthmus
of the gastric mucosal glands10. In vitro studies have shown that PSCA influences survival
in gastric cancer cells, where transfection of PSCA into PSCA-negative cells leads to
reduced cell proliferation10. In contrast, knockdown of PSCA in a bladder cancer cell line
results in induction of inflammatory gene expression, accompanied by a reduction in cell
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grown42. The role of PSCA in tumorigenesis therefore appears complex, involving pro-
tumorigenic and anti-tumorigenic effects in different contexts43.
Few functional clues have been gained from the PSCA knock-out mouse, which is viable,
fertile, and appears not to be tumor-prone44. Insight might better be gleaned by analysis of
the functions of other members of the Ly6 family, which have been shown to be involved in
differentiation, immune homeostasis and T-cell activation45,46. Members of Ly6 protein
family bear a structural resemblance to the snake venom α-bungarotoxin, suggesting that
they may act as ligands in neuronal signaling47. Perhaps the most persuasive functional data
specific to PSCA derive from the chick PSCA ortholog. Hruska et al. observed that
misexpressing PSCA during chick ciliary ganglion development lead to allosteric
antagonism of α7 subunit-containing nicotinic acetylcholine receptors (α7-nAChRs), and
rescued a neuronal subpopulation from programmed cell death48. Interestingly, α7-nAChR-
signalling has been implicated in smoking-related carcinogenesis, and α7-nAChRs are
required for the COX-II induction observed following exposure of gastric cancer cells to
nicotine in vitro49. It is not known whether PSCA interacts with α7-nAChRs in humans; the
related Ly-6 protein, SLURP-1, however, potentiates α7-nAChR signaling in keratinocytes.
In addition, mutations in SLURP-1 have been implicated in the inflammatory skin disorder
Mal de Meleda, suggesting that SLURP-1 has a role in epidermal homeostasis50.
The role of nAChR-signaling in non-neuronal cells has become the focus of much attention
over recent years, particularly in relation to immune modulation and inflammation. The so-
called `cholinergic anti-inflammatory pathway' is exemplified by a rat model where the
systemic inflammatory response to endotoxin is reduced by concomitant vagal
stimulation51. Furthermore, α7 subunit-deficient mice demonstrate an augmented
inflammatory response to endotoxaemia due to loss of acetylcholine-mediated inhibition of
macrophage TNF release52.
It is plausible therefore that PSCA might interact with α7-nAChRs in humans, and that the
rs2294008 polymorphism may influence the balance of pro-inflammatory and anti-
inflammatory signals present in the gastric mucosa. Given that our data implicate PSCA in
the development of atrophic gastritis, it is conceivable that PSCA modifies the host
inflammatory response to H pylori infection. This hypothesis does not exclude potential
additional context-specific roles for PSCA in the regulation of epithelial cell proliferation.
We therefore suggest that the role of PSCA in pro and anti-inflammatory signaling in
humans should be the subject of further scrutiny.
Acknowledgments
Support: The ESTHER study baseline examination and the German analyses on atrophic gastritis were funded by
grants from the Baden-Wuerttemberg Ministry of Science, Research and the Arts. PL is funded by a Scottish
Government Chief Scientist Office fellowship. The US multi-centre esophageal and gastric cancer study was
supported by the United States Public Health Service (U01-CA57983, U01-CA57949, U01-CA57923,
P30ES10126) and by the National Cancer Institute, National Institutes of Health, Department of Health and Human
Services (N02-CP40501, N01-CN05230).
Abbreviations used in this paper
CAG chronic atrophic gastritis
CI confidence interval
EAC esophageal adenocarcinoma
ESCC esophageal squamous cell carcinoma
Lochhead et al. Page 7













GWAS genome wide association study
OR odds ratio
PSCA prostate stem cell antigen
SNP single nucleotide polymorphism
References
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of
cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010
2. Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Serum antibody
prevalence in populations with contrasting cancer risks. Cancer 1990;66:2569–2574. [PubMed:
2249197]
3. Talley NJ, Zinsmeister AR, Weaver A, et al. Gastric adenocarcinoma and Helicobacter pylori
infection. J Natl Cancer Inst 1991;83:1734–1739. [PubMed: 1770552]
4. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with
increased risk of gastric cancer. Nature 2000;404:398–402. [PubMed: 10746728]
5. Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphisms are
associated with increased risk of gastric carcinoma. Gastroenterology 2001;121:823–829. [PubMed:
11606496]
6. Machado JC, Figueiredo C, Canedo P, et al. A proinflammatory genetic profile increases the risk for
chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125:364–371. [PubMed:
12891537]
7. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated
with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003;124:1193–1201.
[PubMed: 12730860]
8. Hold GL, Rabkin CS, Chow WH, et al. A functional polymorphism of toll-like receptor 4 gene
increases risk of gastric carcinoma and its precursors. Gastroenterology 2007;132:905–912.
[PubMed: 17324405]
9. Ioannidis JP, Castaldi P, Evangelou E. A compendium of genome-wide associations for cancer:
critical synopsis and reappraisal. J Natl Cancer Inst 2010;102:846–858. [PubMed: 20505153]
10. Study Group of Millennium Genome Project for Cancer. Sakamoto H, Yoshimura K, et al. Genetic
variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet
2008;40:730–740. [PubMed: 18488030]
11. Wu C, Wang G, Yang M, et al. Two genetic variants in prostate stem cell antigen and gastric
cancer susceptibility in a Chinese population. Mol Carcinog 2009;48:1131–1138. [PubMed:
19554573]
12. Matsuo K, Tajima K, Suzuki T, et al. Association of prostate stem cell antigen gene
polymorphisms with the risk of stomach cancer in Japanese. Int J Cancer 2009;125:1961–1964.
[PubMed: 19582881]
13. Ou J, Li K, Ren H, Bai H, Zeng D, Zhang C. Association and haplotype analysis of prostate stem
cell antigen with gastric cancer in Tibetans. DNA Cell Biol 2010;29:319–323. [PubMed:
20230293]
14. Lu Y, Chen J, Ding Y, et al. Genetic variation of PSCA gene is associated with the risk of both
diffuse- and intestinal-gastric cancer in a Chinese population. Int J Cancer. 2010
15. Abnet CC, Freedman ND, Hu N, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric
adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010;42:764–767.
[PubMed: 20729852]
16. El-Omar EM, Oien K, Murray LS, et al. Increased prevalence of precancerous changes in relatives
of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000;118:22–30. [PubMed:
10611150]
Lochhead et al. Page 8













17. Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Epidemiology of chronic atrophic gastritis:
population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther
2007;26:879–887. [PubMed: 17767472]
18. Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis
on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis
screening. J Med Screen 2004;11:141–147. [PubMed: 15333273]
19. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I,
serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with
pernicious anemia. Gastroenterology 1982;83:204–209. [PubMed: 7084603]
20. Gao L, Weck MN, Michel A, Pawlita M, Brenner H. Association between chronic atrophic
gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology.
Cancer Res 2009;69:2973–2980. [PubMed: 19318564]
21. Gao L, Weck MN, Nieters A, Brenner H. Association between a pro-inflammatory genetic profile
and the risk of chronic atrophic gastritis among older adults from Germany. Eur J Cancer
2009;45:428–434. [PubMed: 19013788]
22. Chow WH, Swanson CA, Lissowska J, et al. Risk of stomach cancer in relation to consumption of
cigarettes, alcohol, tea and coffee in Warsaw, Poland. Int J Cancer 1999;81:871–876. [PubMed:
10362132]
23. Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and
adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997;89:1277–1284.
[PubMed: 9293918]
24. Kormann MS, Carr D, Klopp N, et al. G-Protein-coupled receptor polymorphisms are associated
with asthma in a large German population. Am J Respir Crit Care Med 2005;171:1358–1362.
[PubMed: 15764725]
25. Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal
1999;14:143–149. [PubMed: 10084106]
26. Li Y, Holzgreve W, Kiefer V, Hahn S. Maldi-tof mass spectrometry compared with real-time PCR
for detection of fetal cell-free DNA in maternal plasma. Clin Chem 2006;52:2311–2312.
[PubMed: 17138855]
27. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic
association studies. Genet Med 2002;4:45–61. [PubMed: 11882781]
28. Derakhshan MH, Malekzadeh R, Watabe H, et al. Combination of gastric atrophy, reflux
symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut
2008;57:298–305. [PubMed: 17965056]
29. de Martel C, Llosa AE, Farr SM, et al. Helicobacter pylori infection and the risk of development of
esophageal adenocarcinoma. J Infect Dis 2005;191:761–767. [PubMed: 15688293]
30. Anderson LA, Murphy SJ, Johnston BT, et al. Relationship between Helicobacter pylori infection
and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma
sequence: results from the FINBAR case-control study. Gut 2008;57:734–739. [PubMed:
18025067]
31. Iijima K, Koike T, Abe Y, et al. Gastric hyposecretion in esophageal squamous-cell carcinomas.
Dig Dis Sci 2010;55:1349–1355. [PubMed: 19513836]
32. Park SL, Chang SC, Cai L, et al. Associations between variants of the 8q24 chromosome and nine
smoking-related cancer sites. Cancer Epidemiol Biomarkers Prev 2008;17:3193–3202. [PubMed:
18990762]
33. Reiter RE, Gu Z, Watabe T, et al. Prostate stem cell antigen: a cell surface marker overexpressed in
prostate cancer. Proc Natl Acad Sci U S A 1998;95:1735–1740. [PubMed: 9465086]
34. Gu Z, Thomas G, Yamashiro J, et al. Prostate stem cell antigen (PSCA) expression increases with
high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene
2000;19:1288–1296. [PubMed: 10713670]
35. Han KR, Seligson DB, Liu X, et al. Prostate stem cell antigen expression is associated with gleason
score, seminal vesicle invasion and capsular invasion in prostate cancer. J Urol 2004;171:1117–
1121. [PubMed: 14767283]
Lochhead et al. Page 9













36. Lam JS, Yamashiro J, Shintaku IP, et al. Prostate stem cell antigen is overexpressed in prostate
cancer metastases. Clin Cancer Res 2005;11:2591–2596. [PubMed: 15814638]
37. Argani P, Rosty C, Reiter RE, et al. Discovery of new markers of cancer through serial analysis of
gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer
Res 2001;61:4320–4324. [PubMed: 11389052]
38. Amara N, Palapattu GS, Schrage M, et al. Prostate stem cell antigen is overexpressed in human
transitional cell carcinoma. Cancer Res 2001;61:4660–4665. [PubMed: 11406532]
39. Elsamman EM, Fukumori T, Tanimoto S, et al. The expression of prostate stem cell antigen in
human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain
reaction analysis. BJU Int 2006;98:668–673. [PubMed: 16925770]
40. Cao D, Ji H, Ronnett BM. Expression of mesothelin, fascin, and prostate stem cell antigen in
primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous
tumors from metastatic pancreatic mucinous carcinomas in the ovary. Int J Gynecol Pathol
2005;24:67–72. [PubMed: 15626919]
41. Bahrenberg G, Brauers A, Joost HG, Jakse G. Reduced expression of PSCA, a member of the
LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem
Biophys Res Commun 2000;275:783–788. [PubMed: 10973799]
42. Marra E, Uva P, Viti V, et al. Growth delay of human bladder cancer cells by Prostate Stem Cell
Antigen downregulation is associated with activation of immune signaling pathways. BMC Cancer
2010;10:129. [PubMed: 20374648]
43. Saeki N, Gu J, Yoshida T, Wu X. Prostate stem cell antigen: a Jekyll and Hyde molecule? Clin
Cancer Res 2010;16:3533–3538. [PubMed: 20501618]
44. Moore ML, Teitell MA, Kim Y, et al. Deletion of PSCA increases metastasis of TRAMP-induced
prostate tumors without altering primary tumor formation. Prostate 2008;68:139–151. [PubMed:
18044730]
45. Presky DH, Low MG, Shevach EM. Role of phosphatidylinositol-anchored proteins in T cell
activation. J Immunol 1990;144:860–868. [PubMed: 1967276]
46. Gumley TP, McKenzie IF, Sandrin MS. Tissue expression, structure and function of the murine
Ly-6 family of molecules. Immunol Cell Biol 1995;73:277–296. [PubMed: 7493764]
47. Tsetlin V. Snake venom alpha-neurotoxins and other `three-finger' proteins. Eur J Biochem
1999;264:281–286. [PubMed: 10491072]
48. Hruska M, Keefe J, Wert D, et al. Prostate stem cell antigen is an endogenous lynx1-like
prototoxin that antagonizes alpha7-containing nicotinic receptors and prevents programmed cell
death of parasympathetic neurons. J Neurosci 2009;29:14847–14854. [PubMed: 19940180]
49. Shin VY, Jin HC, Ng EK, et al. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic
acetylcholine receptor (nAChR) and beta-adrenergic receptor signaling pathways. Toxicol Appl
Pharmacol 2008;233:254–261. [PubMed: 18805435]
50. Chimienti F, Hogg RC, Plantard L, et al. Identification of SLURP-1 as an epidermal
neuromodulator explains the clinical phenotype of Mal de Meleda. Hum Mol Genet
2003;12:3017–3024. [PubMed: 14506129]
51. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic
inflammatory response to endotoxin. Nature 2000;405:458–462. [PubMed: 10839541]
52. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential
regulator of inflammation. Nature 2003;421:384–388. [PubMed: 12508119]
Lochhead et al. Page 10




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Gastroenterology. Author manuscript; available in PMC 2012 February 1.
